Do Surgical Robots Need a Second Opinion?
What was it that Ben Franklin said: “An ounce of prevention is worth a pound of cure.” A recent paper, Robotic Surgery & The Law in the USA—A Critique, indicates that manufacturers of robotic surgical tools, a sizeable swath of the U.S. medical establishment and government officials seem to prefer the pound of cure. RBR50 company Intuitive Surgical‘s new da Vinci Xi just won the approval of the U.S. Food and Drug Administration (FDA), paving the way for the company to start selling it. More than a decade previous, 2000, the FDA similarly approved Intuitive’s very first da Vinci; the company has since racked up some 1.5M robotic surgeries with its robots. However, as Sulbha Sankhla, author of Robotic Surgery & The Law in the USA—A Critique, points out: “Years after the FDA first approved the da Vinci, there is still no industry standard for training and credentialing of doctors to use the robot, beyond a basic course by the manufacturer.” It seems rath...